UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 287

Sortiert nach

Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site

Molecular metabolism (Germany), 2022-08, Vol.62, p.101522, Article 101522

2022

Volltextzugriff (PDF)

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets

Diabetes (New York, N.Y.), 2010-12, Vol.59 (12), p.3099-3107

2010

Volltextzugriff (PDF)

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis

Diabetes, obesity & metabolism, 2022-01, Vol.24 (1), p.148-153

2022

Volltextzugriff (PDF)

Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation

The Journal of biological chemistry, 2006-12, Vol.281 (52), p.39831-39838

2006

Volltextzugriff (PDF)

Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism

Diabetes (New York, N.Y.), 2005-06, Vol.54 (6), p.1846-1853

2005

Volltextzugriff (PDF)

Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam

Journal of controlled release, 2022-02, Vol.342, p.189-200

2022

Volltextzugriff (PDF)

Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam

Journal of controlled release, 2023-01, Vol.353, p.823-831

2023

Volltextzugriff (PDF)

β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy

Endocrinology (Philadelphia), 2016-09, Vol.157 (9), p.3405-3409

2016

Volltextzugriff (PDF)

Insulin, Not the Preservative m-cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine

Journal of pharmaceutical sciences, 2021-03, Vol.110 (3), p.1418-1426

2021

Volltextzugriff (PDF)

Characterization and quantification of oxyntomodulin in human and rat plasma using high-resolution accurate mass LC-MS

Bioanalysis, 2016-08, Vol.8 (15), p.1579-1595

2016

Volltextzugriff (PDF)

Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease

The Journal of biological chemistry, 2007-06, Vol.282 (26), p.19113-19121

2007

Volltextzugriff (PDF)

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

The Journal of clinical investigation, 2004-06, Vol.113 (11), p.1571-1581

2004

Volltextzugriff (PDF)

Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

The Journal of clinical investigation, 2004-06, Vol.113 (11), p.1571-1581

2004

Volltextzugriff (PDF)

The Effects of Weighted Vests on Appropriate In-Seat Behaviors of Elementary-Age Students With Autism and Severe to Profound Intellectual Disabilities

Focus on autism and other developmental disabilities, 2009-03, Vol.24 (1), p.17-26

2009

Volltextzugriff (PDF)

Hybrid insulin cocrystals for controlled release delivery

Nature biotechnology, 2002-08, Vol.20 (8), p.800-804

2002

Volltextzugriff (PDF)

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p ost hoc analysis

Diabetes, obesity & metabolism, 2022-01, Vol.24 (1), p.148-153

2022

Volltextzugriff (PDF)

Abstract 13426: The Dual GIP/GLP-1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Protein Biomarkers in Patients With Type 2 Diabetes

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A13426-A13426

2020

Volltextzugriff (PDF)

[beta]-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy

Endocrinology (Philadelphia), 2016-09, Vol.157 (9), p.3405-3409

2016

Volltextzugriff (PDF)

Determining Oxidation-Reduction on a Simple Number Line

Journal of chemical education, 2002-08, Vol.79 (8), p.965

2002

Volltextzugriff (PDF)

Insulin-XTEN® Exhibits a Size-Dependent Alteration in Tissue Action in Rats

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Novel Small Molecule Glucagon-Like Peptide-1 Preceptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets

Diabetes (New York, N.Y.), 2010, Vol.59 (12), p.3099-3107

2010

Volltextzugriff (PDF)

The hypoglycemic effect of the GLP-1 analogue LY307161 is self-limiting in normal, fasted dogs

Diabetes research and clinical practice, 2000-09, Vol.50, p.384-384

2000

Volltextzugriff (PDF)

The New Buffalo: Tribal Gaming as a Means of Subsistence Under Attack

Boston College environmental affairs law review, 1998-07, Vol.25 (4), p.863-911

Cox, Amy L

1998

Volltextzugriff (PDF)

DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy

PLoS genetics, 2017-03, Vol.13 (3), p.e1006658-e1006658

2017

Volltextzugriff (PDF)

RNA viruses in hymenopteran pollinators: evidence of inter-Taxa virus transmission via pollen and potential impact on non-Apis hymenopteran species

PloS one, 2010-12, Vol.5 (12), p.e14357

2010

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(259)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(287)
Japanisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis

Farnesoid X Receptor Agonist Reduces Serum Asymmetric Dimethylarginine Levels through Hepatic Dimethylarginine Dimethylaminohydrolase-1 Gene Regulation

Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism

Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam

Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam

β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy

Insulin, Not the Preservative m-cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine

Characterization and quantification of oxyntomodulin in human and rat plasma using high-resolution accurate mass LC-MS

Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

The Effects of Weighted Vests on Appropriate In-Seat Behaviors of Elementary-Age Students With Autism and Severe to Profound Intellectual Disabilities

Hybrid insulin cocrystals for controlled release delivery

The dual glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p ost hoc analysis

Abstract 13426: The Dual GIP/GLP-1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Protein Biomarkers in Patients With Type 2 Diabetes

[beta]-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy

Determining Oxidation-Reduction on a Simple Number Line

Insulin-XTEN® Exhibits a Size-Dependent Alteration in Tissue Action in Rats

Novel Small Molecule Glucagon-Like Peptide-1 Preceptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets

The hypoglycemic effect of the GLP-1 analogue LY307161 is self-limiting in normal, fasted dogs

The New Buffalo: Tribal Gaming as a Means of Subsistence Under Attack

DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy

RNA viruses in hymenopteran pollinators: evidence of inter-Taxa virus transmission via pollen and potential impact on non-Apis hymenopteran species

Suchergebnisse filtern